Načítá se...
SAT-576 Possible Involvement of Thyroid Function in PCSK9 Inhibitor Therapy
INTRODUCTION Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibition is an effective strategy for lowering plasma LDL-cholesterol and enhancing the LDL-cholesterol lowering ability of statins. PCSK9, a serine protease that binds to the LDL receptor promoting its degradation, is an important...
Uloženo v:
| Vydáno v: | J Endocr Soc |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7209628/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.477 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|